{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:23:36Z","timestamp":1787696616581,"version":"build-2784847793"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer US","isbn-type":[{"value":"9781071650714","type":"print"},{"value":"9781071650721","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5072-1_15","type":"book-chapter","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:03:47Z","timestamp":1787695427000},"page":"383-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dissecting Epigenetic Drug Response Mechanisms Using CRISPR Knockout Screens"],"prefix":"10.1007","author":[{"given":"Xinyue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"5","key":"15_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrg3899","volume":"16","author":"O Shalem","year":"2015","unstructured":"Shalem O, Sanjana NE, Zhang F (2015) High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet 16(5):299\u2013311. https:\/\/doi.org\/10.1038\/nrg3899","journal-title":"Nat Rev Genet"},{"issue":"6096","key":"15_CR2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816\u2013821. https:\/\/doi.org\/10.1126\/science.1225829","journal-title":"Science"},{"issue":"6213","key":"15_CR3","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1258096. https:\/\/doi.org\/10.1126\/science.1258096","journal-title":"Science"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","volume":"447","author":"M Chen","year":"2019","unstructured":"Chen M, Mao A, Xu M, Weng Q, Mao J, Ji\u00a0J (2019) CRISPR-Cas9 for cancer therapy: opportunities and challenges. Cancer Lett 447:48\u201355. https:\/\/doi.org\/10.1016\/j.canlet.2019.01.017","journal-title":"Cancer Lett"},{"issue":"5","key":"15_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41568-022-00441-w","volume":"22","author":"A Katti","year":"2022","unstructured":"Katti A, Diaz BJ, Caragine CM, Sanjana\u00a0NE, Dow\u00a0LE (2022) CRISPR in cancer biology and therapy. Nat Rev Cancer 22(5):259\u2013279. https:\/\/doi.org\/10.1038\/s41568-022-00441-w","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"15_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"K Tzelepis","year":"2016","unstructured":"Tzelepis K, Koike-Yusa H, De Braekeleer\u00a0E, Li Y, Metzakopian E, Dovey OM, Mupo A, Grinkevich V, Li M, Mazan M, Gozdecka\u00a0M, Ohnishi S, Cooper J, Patel M, McKerrell\u00a0T, Chen B, Domingues AF, Gallipoli P, Teichmann S, Ponstingl H, McDermott U, Saez-Rodriguez J, Huntly BJP, Iorio F, Pina C, Vassiliou GS, Yusa K (2016) A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep 17(4):1193\u20131205. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.079","journal-title":"Cell Rep"},{"issue":"5","key":"15_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.stem.2020.04.003","volume":"26","author":"BE Michels","year":"2020","unstructured":"Michels BE, Mosa MH, Streibl BI, Zhan T, Menche C, Abou-El-Ardat K, Darvishi T, Cz\u0142onka E, Wagner S, Winter J, Medyouf H, Boutros M, Farin HF (2020) Pooled in vitro and in vivo CRISPR-Cas9 screening identifies tumor suppressors in human colon organoids. Cell Stem Cell 26(5):782\u2013792. https:\/\/doi.org\/10.1016\/j.stem.2020.04.003 e787","journal-title":"Cell Stem Cell"},{"key":"15_CR8","doi-asserted-by":"publisher","unstructured":"Zhang H, Zhang Y, Zhou X, Wright S, Hyle J, Zhao L, An J, Zhao X, Shao Y, Xu B, Lee HM, Chen T, Zhou Y, Chen X, Lu R, Li C (2020) Functional interrogation of HOXA9 regulome in MLLr leukemia via reporter-based CRISPR\/Cas9 screen. eLife 9. https:\/\/doi.org\/10.7554\/eLife.57858","DOI":"10.7554\/eLife.57858"},{"issue":"5","key":"15_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nbt.3834","volume":"35","author":"K Han","year":"2017","unstructured":"Han K, Jeng EE, Hess GT, Morgens DW, Li\u00a0A, Bassik MC (2017) Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions. Nat Biotechnol 35(5):463\u2013474. https:\/\/doi.org\/10.1038\/nbt.3834","journal-title":"Nat Biotechnol"},{"issue":"2","key":"15_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE (2016) Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol 34(2):184\u2013191. https:\/\/doi.org\/10.1038\/nbt.3437","journal-title":"Nat Biotechnol"},{"issue":"6166","key":"15_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.1246981","volume":"343","author":"T Wang","year":"2014","unstructured":"Wang T, Wei JJ, Sabatini DM, Lander ES (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science 343(6166):80\u201384. https:\/\/doi.org\/10.1126\/science.1246981","journal-title":"Science"},{"issue":"8","key":"15_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1158\/2159-8290.Cd-16-0154","volume":"6","author":"AJ Aguirre","year":"2016","unstructured":"Aguirre AJ, Meyers RM, Weir BA, Vazquez\u00a0F, Zhang CZ, Ben-David U, Cook A, Ha G, Harrington WF, Doshi MB, Kost-Alimova M, Gill S, Xu H, Ali LD, Jiang G, Pantel S, Lee\u00a0Y, Goodale A, Cherniack AD, Oh C, Kryukov\u00a0G, Cowley GS, Garraway LA, Stegmaier K, Roberts CW, Golub TR, Meyerson M, Root DE, Tsherniak A, Hahn WC (2016) Genomic copy number dictates a gene-independent cell response to CRISPR\/Cas9 targeting. Cancer Discov 6(8):914\u2013929. https:\/\/doi.org\/10.1158\/2159-8290.Cd-16-0154","journal-title":"Cancer Discov"},{"issue":"6264","key":"15_CR13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.aac7041","volume":"350","author":"T Wang","year":"2015","unstructured":"Wang T, Birsoy K, Hughes NW, Krupczak\u00a0KM, Post Y, Wei JJ, Lander ES, Sabatini DM (2015) Identification and characterization of essential genes in the human genome. Science 350(6264):1096\u20131101. https:\/\/doi.org\/10.1126\/science.aac7041","journal-title":"Science"},{"issue":"1","key":"15_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41375-022-01741-8","volume":"37","author":"X Zhou","year":"2023","unstructured":"Zhou X, Zhang P, Aryal S, Zhang L, Lu R (2023) UTX loss alters therapeutic responses in KMT2A-rearranged acute myeloid leukemia. Leukemia 37(1):226\u2013230. https:\/\/doi.org\/10.1038\/s41375-022-01741-8","journal-title":"Leukemia"},{"issue":"5","key":"15_CR15","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nprot.2018.005","volume":"13","author":"MC Canver","year":"2018","unstructured":"Canver MC, Haeussler M, Bauer DE, Orkin SH, Sanjana NE, Shalem O, Yuan GC, Zhang F, Concordet JP, Pinello L (2018) Integrated design, execution, and analysis of arrayed and pooled CRISPR genome-editing experiments. Nat Protoc 13(5):946\u2013986. https:\/\/doi.org\/10.1038\/nprot.2018.005","journal-title":"Nat Protoc"},{"key":"15_CR16","doi-asserted-by":"publisher","unstructured":"Zhou X, Zhang L, Aryal S, Veasey V, Tajik A, Restelli C, Moreira S, Zhang P, Zhang Y, Hope K.J, Zhou Y, Cheng C, Bhatia R, Lu R (2024) Epigenetic regulation of noncanonical menin targets modulates menin inhibitor response in acute myeloid leukemia. Blood 144, 2018-2032. https:\/\/doi.org\/10.1182\/blood.2023023644","DOI":"10.1182\/blood.2023023644"},{"issue":"12","key":"15_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang\u00a0F, Irizarry RA, Liu JS, Brown M, Liu XS (2014) MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol 15(12), 554. https:\/\/doi.org\/10.1186\/s13059-014-0554-4","journal-title":"Genome Biol"},{"key":"15_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0843-6","volume":"16","author":"W Li","year":"2015","unstructured":"Li W, K\u00f6ster J, Xu H, Chen CH, Xiao T, Liu JS, Brown M, Liu XS (2015) Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol 16, 281. https:\/\/doi.org\/10.1186\/s13059-015-0843-6","journal-title":"Genome Biol"},{"issue":"12","key":"15_CR19","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ (2013) Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods 10(12):1213\u20131218. https:\/\/doi.org\/10.1038\/nmeth.2688","journal-title":"Nat Methods"}],"container-title":["Methods in Molecular Biology","Cancer Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5072-1_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:03:48Z","timestamp":1787695428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5072-1_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650714","9781071650721"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5072-1_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}